Prof. Dr. Dolores Di Vizio | Biochemistry | Best Researcher Award
Professor at Cedars-Sinai Medical Center, United States
Dr. Dolores Di Vizio is a globally recognized physician-scientist whose research has significantly advanced the fields of cancer biology, extracellular vesicles (EVs), and translational oncology. She holds multiple academic positions at Cedars-Sinai Medical Center and plays a leading role in international scientific organizations. Dr. Di Vizio is best known for pioneering the discovery of large oncosomes, a novel type of extracellular vesicle implicated in cancer progression and metastasis.
Publication Profile
Educational Background
-
M.D., University of Naples Federico II, Italy
-
Ph.D., University of Naples Federico II, Italy
(with postdoctoral training at Harvard Medical School)
Professional Experience
-
Professor, Departments of Surgery, Pathology & Laboratory Medicine, and Biomedical Sciences
Cedars-Sinai Medical Center, Los Angeles, CA -
Co-Director, Cancer Biology Program
Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai -
Visiting Faculty
-
Yonsei University, Korea
-
University of Calabria, Italy
-
IRCCS Regina Elena, Italy
-
-
Former Faculty,
Harvard Medical School -
Editorial and Leadership Roles
-
Deputy Editor, Journal of Extracellular Vesicles (JEV)
-
Editorial Boards: Oncotarget, Biomedicines, Frontiers in Oncology, and others
-
Chair/Organizer: Gordon Research Conferences, ISEV 2021 & 2023
-
Member: NIH TPM Study Section, DoD Prostate Cancer Program, ERC Review Panel
-
Research Interests
-
Extracellular Vesicles (EVs) & Large Oncosomes:
Discovery, molecular profiling, and diagnostic applications. -
Cancer Metastasis & Progression:
Mechanisms of tumor dissemination, especially in prostate cancer. -
Molecular Oncology & Signal Transduction:
Role of cytoskeletal remodeling and intercellular communication in cancer. -
Translational Research:
Development of EV-based diagnostics and therapeutic targets.
Awards and Honors
-
Over $10 Million in Competitive Research Funding:
-
NIH R01 Grants
-
Department of Defense (DoD)
-
Avon Foundation
-
American Italian Cancer Foundation (AICF)
-
-
Chair/Co-chair of International Conferences:
-
Gordon Research Conference (2020)
-
ISEV 2021 & 2023
-
-
Invited Speaker:
Over 70 national and international institutions, including Nature Webinars, Keystone Symposia, NIH, and AACR. -
Mentorship Awards and Leadership in Education
-
Mentor for DoD and SPORE programs
-
Participant in NIH T32, R25, and CTSI training programs
-
Conclusion
Dr. Dolores Di Vizio is an internationally respected expert in cancer biology and extracellular vesicle research. Her innovative discoveries, particularly in EV biology and cancer metastasis, have earned her global recognition and continuous research support. Her leadership in academic, clinical, and scientific communities, combined with a deep commitment to mentorship and collaboration, makes her one of the most impactful physician-scientists of her generation. She is an ideal candidate for high-level research honors and awards, with a career that exemplifies scientific innovation, translational impact, and educational excellence.
Publications
-
Title: Extracellular vesicle heterogeneity through the lens of multiomics
Journal: Cell Reports Medicine
Type: Article
Year: 2025
-
Title: Roadblocks of Urinary EV Biomarkers: Moving Toward the Clinic
Type: Review
Year: 2025
-
Title: Emerin Dysregulation Drives the Very-Small-Nuclear Phenotype and Lineage Plasticity That Associate with a Clinically Aggressive Subtype of Prostate Cancer
Journal: Clinical Cancer Research
Type: Article
Year: 2025
-
Title: A class of large cell-like extracellular vesicles: Extracellular vesicles
Journal: Nature Cell Biology
Type: Article
Year: 2025
Citations: 3
-
Title: Mechanisms governing lineage plasticity and metabolic reprogramming in cancer
Type: Review
Year: 2025
Citations: 3
-
Title: ONECUT2 acts as a lineage plasticity driver in adenocarcinoma as well as neuroendocrine variants of prostate cancer
Journal: Nucleic Acids Research
Type: Article
Year: 2024
Citations: 11
-
Title: Multiparametric Single-Vesicle Flow Cytometry Resolves Extracellular Vesicle Heterogeneity and Reveals Selective Regulation of Biogenesis and Cargo Distribution
Journal: ACS Nano
Type: Article
Year: 2024
Citations: 15
-
Title: Hepatic prohibitin 1 and methionine adenosyltransferase α1 defend against primary and secondary liver cancer metastasis
Journal: Journal of Hepatology
Type: Article
Year: 2024
Citations: 7
-
Title: Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches
Journal: Journal of Extracellular Vesicles
Type: Article
Year: 2024
Citations: 1,465
-
Title: International Society for Extracellular Vesicles workshop. QuantitatEVs: Multiscale analyses, from bulk to single extracellular vesicle
Journal: Journal of Extracellular Biology
Type: Article
Year: 2024